The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy
出版年份 2023 全文链接
标题
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy
作者
关键词
-
出版物
Lancet Gastroenterology & Hepatology
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-10-20
DOI
10.1016/s2468-1253(23)00207-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy
- (2023) Gaopeng Li et al. CANCER CELL
- The emerging roles of γδ T cells in cancer immunotherapy
- (2023) Sofia Mensurado et al. Nature Reviews Clinical Oncology
- Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
- (2023) Chiara Falcomatà et al. Cancer Discovery
- GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia
- (2023) Ja Young Kim-Muller et al. Cell Reports
- Spatially Resolved Multi-Omics Single-Cell Analyses Inform Mechanisms of Immune Dysfunction in Pancreatic Cancer
- (2023) Suhail Yousuf et al. GASTROENTEROLOGY
- Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments
- (2023) Zhennan Yuan et al. Molecular Cancer
- Pan-KRAS inhibitor disables oncogenic signalling and tumour growth
- (2023) Dongsung Kim et al. NATURE
- Programmable protein delivery with a bacterial contractile injection system
- (2023) Joseph Kreitz et al. NATURE
- Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
- (2023) Luis A. Rojas et al. NATURE
- Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
- (2023) Yanshuo Chu et al. NATURE MEDICINE
- The extracellular matrix and the immune system: A mutually dependent relationship
- (2023) Tara E. Sutherland et al. SCIENCE
- Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment
- (2023) Gregor Werba et al. Nature Communications
- Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma
- (2023) Charlie Saillard et al. Nature Communications
- Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: an AGEO European Cohort
- (2023) Julien Taïeb et al. EUROPEAN JOURNAL OF CANCER
- Obesity, cancer, and response to immune checkpoint inhibitors: Could the gut microbiota be the mechanistic link?
- (2023) Matthieu Delaye et al. PHARMACOLOGY & THERAPEUTICS
- Direct targeting of RAS in pancreatic ductal adenocarcinoma with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RASMULTI(ON) inhibitor.
- (2022) W. Clay Gustafson et al. JOURNAL OF CLINICAL ONCOLOGY
- Squidpy: a scalable framework for spatial omics analysis
- (2022) Giovanni Palla et al. NATURE METHODS
- Tertiary lymphoid structures in cancer
- (2022) Ton N. Schumacher et al. SCIENCE
- Immunological Classification of Pancreatic Carcinomas to Identify Immune Index and Provide a Strategy for Patient Stratification
- (2022) Yi Chen et al. Frontiers in Immunology
- Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer
- (2022) Emma Kurz et al. CANCER CELL
- Multicellular Modelling of Difficult-to-Treat Gastrointestinal Cancers: Current Possibilities and Challenges
- (2022) Sarah K. Hakuno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer‐associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets
- (2022) Shinelle Menezes et al. JOURNAL OF PATHOLOGY
- Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
- (2022) Marta Łuksza et al. NATURE
- Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer
- (2022) Rom Leidner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab/Nivolumab Therapy in Patients With Metastatic Pancreatic or Biliary Cancer With Homologous Recombination Deficiency Pathogenic Germline Variants
- (2022) Gretel Terrero et al. JAMA Oncology
- Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors
- (2022) Rocio Garcia-Carbonero et al. Journal for ImmunoTherapy of Cancer
- Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy
- (2022) Jiaqi Yang et al. EBioMedicine
- Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma
- (2022) Ioana Plesca et al. Cancers
- An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer
- (2022) Maryum Nisar et al. Frontiers in Oncology
- Targeting CD47/SIRPα as a therapeutic strategy, where we are and where we are headed
- (2022) Tailong Qu et al. Biomarker Research
- Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer
- (2022) Yang Chen et al. CANCER CELL
- Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I study
- (2022) S.P. Lau et al. EUROPEAN JOURNAL OF CANCER
- Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2022) Hedy L. Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial
- (2022) Kim A Reiss et al. LANCET ONCOLOGY
- Tumour inhibitory activity on pancreatic cancer by bispecific nanobody targeting PD-L1 and CXCR4
- (2022) Shuai Hao et al. BMC CANCER
- Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors
- (2022) Aung Naing et al. CANCER
- Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy
- (2022) Yu Fujiwara et al. CANCER TREATMENT REVIEWS
- The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma
- (2022) Daniel J. Renouf et al. Nature Communications
- Macrophages in health and disease
- (2022) Matthew D. Park et al. CELL
- A Transcriptomic-Based Tool to Predict Gemcitabine Sensitivity in Advanced Pancreatic Adenocarcinoma
- (2022) Nicolas Fraunhoffer et al. GASTROENTEROLOGY
- Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
- (2022) Jorge Luis Galeano Niño et al. NATURE
- Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer
- (2022) John H. Strickler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer
- (2022) Samantha B. Kemp et al. Cancer Discovery
- Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
- (2021) Jiali Yu et al. NATURE MEDICINE
- Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study
- (2021) M. Tempero et al. ANNALS OF ONCOLOGY
- IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions
- (2021) Gianluca Mucciolo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- KRAS drives immune evasion in a genetic model of pancreatic cancer
- (2021) Irene Ischenko et al. Nature Communications
- Microbiome and pancreatic ductal adenocarcinoma
- (2021) Annemilaï Tijeras-Raballand et al. Clinics and Research in Hepatology and Gastroenterology
- Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome
- (2021) Shannon M. Liudahl et al. Cancer Discovery
- Estimated Projection of US Cancer Incidence and Death to 2040
- (2021) Lola Rahib et al. JAMA Network Open
- Modeling pancreatic cancer in mice for experimental therapeutics
- (2021) Kavita Mallya et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
- (2021) Kazuhiro Koikawa et al. CELL
- Squamousness gain defines pancreatic ductal adenocarcinoma hepatic metastases phenotype, and gemcitabine response
- (2021) Nicolas A. Fraunhoffer et al. EUROPEAN JOURNAL OF CANCER
- Pancreatic Cancer Progression in a Patient With Lynch Syndrome Receiving Immunotherapy: A Cautionary Tale
- (2021) Yifan Wang et al. Journal of the National Comprehensive Cancer Network
- Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis
- (2021) Edoardo Del Poggetto et al. SCIENCE
- Exercise and the immune system: taking steps to improve responses to cancer immunotherapy
- (2021) Michael P Gustafson et al. Journal for ImmunoTherapy of Cancer
- Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions
- (2021) Rita T. Lawlor et al. Cancers
- DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis
- (2021) Jenying Deng et al. JCI Insight
- Spatially confined sub-tumor microenvironments in pancreatic cancer
- (2021) Barbara T. Grünwald et al. CELL
- NOX4: a potential therapeutic target for pancreatic cancer and its mechanism
- (2021) Yawei Bi et al. Journal of Translational Medicine
- Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
- (2021) Christine N. Spencer et al. SCIENCE
- Interferon Genes Are Influenced by 17β-Estradiol in SLE
- (2021) Ram P. Singh et al. Frontiers in Immunology
- Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches
- (2021) Linh-Huyen Truong et al. Cancers
- Clinical Impact of Molecular Subtyping of Pancreatic Cancer
- (2021) Zhou Xu et al. Frontiers in Cell and Developmental Biology
- The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
- (2021) Yueqin Sun et al. Frontiers in Cell and Developmental Biology
- Tumor Cell–Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer
- (2020) Shipra Das et al. CANCER RESEARCH
- CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes
- (2020) Mirjana Efremova et al. Nature Protocols
- Regulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis
- (2020) Yaqing Zhang et al. Cancer Discovery
- Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
- (2020) Samarth Hegde et al. CANCER CELL
- Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
- (2020) Nathiya Muthalagu et al. Cancer Discovery
- The Effects of Obesity on Anti-Cancer Immunity and Cancer Immunotherapy
- (2020) Matthew J. Woodall et al. Cancers
- Enhancing the Efficacy of CAR T Cells in the Tumor Microenvironment of Pancreatic Cancer
- (2020) Janina Henze et al. Cancers
- Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
- (2020) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Interleukin-17–induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer
- (2020) Yu Zhang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
- (2020) Yunzhen Qian et al. Journal of Hematology & Oncology
- Targeting STAT3 in Cancer Immunotherapy
- (2020) Sailan Zou et al. Molecular Cancer
- Proton-driven transformable nanovaccine for cancer immunotherapy
- (2020) Ningqiang Gong et al. Nature Nanotechnology
- Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion
- (2020) Marc Hilmi et al. Cancers
- Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies
- (2020) Meghan A. Cupp et al. BMC Medicine
- Preclinical Characterization of HPN536, a Trispecific, T-Cell–Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid Tumors
- (2020) Mary Ellen Molloy et al. CLINICAL CANCER RESEARCH
- Nerve fibers in the tumor microenvironment in neurotropic cancer—pancreatic cancer and cholangiocarcinoma
- (2020) Xiuxiang Tan et al. ONCOGENE
- Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
- (2019) Thiago A. Patente et al. Frontiers in Immunology
- Specialized dendritic cells induce tumor-promoting IL-10+IL-17+ FoxP3neg regulatory CD4+ T cells in pancreatic carcinoma
- (2019) Rocky M. Barilla et al. Nature Communications
- Neutrophils escort circulating tumour cells to enable cell cycle progression
- (2019) Barbara Maria Szczerba et al. NATURE
- Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity
- (2019) Andrea Padoan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neutrophil plasticity in the tumor microenvironment
- (2019) Morgan Giese et al. BLOOD
- Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion
- (2019) Hong Jiang et al. GUT
- STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
- (2019) Weiqing Jing et al. Journal for ImmunoTherapy of Cancer
- Macrophages and Metabolism in the Tumor Microenvironment
- (2019) Ilio Vitale et al. Cell Metabolism
- Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
- (2019) Magdalena Jarosz-Biej et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- (2019) Eileen M. O’Reilly et al. JAMA Oncology
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Aurelien Marabelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
- (2018) Marc Hilmi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
- (2018) Smruti Pushalkar et al. Cancer Discovery
- Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy
- (2018) Imerio Capone et al. Frontiers in Immunology
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- Tumor-Infiltrating NETs Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma
- (2018) Wei Jin et al. ANNALS OF SURGICAL ONCOLOGY
- Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma
- (2018) Ujjwal Mukund Mahajan et al. GASTROENTEROLOGY
- Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
- (2018) Francesco Puleo et al. GASTROENTEROLOGY
- Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
- (2018) Christian U. Blank et al. NATURE MEDICINE
- Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status
- (2018) Romain Cohen et al. JAMA Oncology
- Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade
- (2018) Giuseppe Lo Russo et al. CLINICAL CANCER RESEARCH
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
- (2017) Vinod P. Balachandran et al. NATURE
- Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
- (2017) Julienne L. Carstens et al. Nature Communications
- DNA Damage and Repair Biomarkers of Immunotherapy Response
- (2017) Kent W. Mouw et al. Cancer Discovery
- γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
- (2016) Donnele Daley et al. CELL
- Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer
- (2015) N Hiraoka et al. BRITISH JOURNAL OF CANCER
- Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
- (2014) Andrew D. Rhim et al. CANCER CELL
- Prevailing Role of Contact Guidance in Intrastromal T-cell Trapping in Human Pancreatic Cancer
- (2014) N. Hartmann et al. CLINICAL CANCER RESEARCH
- Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
- (2013) D. E. Sanford et al. CLINICAL CANCER RESEARCH
- A High-Fat Diet Activates Oncogenic Kras and COX2 to Induce Development of Pancreatic Ductal Adenocarcinoma in Mice
- (2013) Bincy Philip et al. GASTROENTEROLOGY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer
- (2013) Dung T. Le et al. JOURNAL OF IMMUNOTHERAPY
- Pancreatic Cancer—Could It Be that Simple? A Different Context of Vulnerability
- (2009) Daniel D. Von Hoff et al. CANCER CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started